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Summary
Natural killer (NK) cells are CD3TCR - , CD16+, CD56+ large granular lymphocytes capable
ofrecognizing and eliminating a variety ofvirus-infected, malignant, and antibody-coated target
cells. Two functionally distinct populations of peripheral blood NK cells can be differentiated
by their surface expression of an isoform of the neural cell adhesion molecule (CD56) . CD56bright
NK cells have the attributes of an undifferentiated cell, in that they proliferate in response to
exogenous cytokines, but exert poor cytolytic activity. CD56dim NK cells have the attributes
of a more differentiated cell, in that they proliferate poorly in response to exogenous cytokines,
but are potent rytolytic effector cells. Here we describe the molecular characterization of a NK
cell restricted epitope (PEN5) that is selectively expressed on the functionally differentiated
CD56dim NK cells . PEN5+ NK cells proliferate poorly in response to interleukin 2 (IL-2), but
are potent cytolytic effectors, whereas PEN5 - NK cells proliferate in response to IL-2, but are
poor cytolytic effectors . Biochemical and immunochemical analyses reveal the PEN5 epitope to
be an unusual sulfated poly-N-lactosamine carbohydrate related to keratan sulfate glycosaminoglycans.
Immunoprecipitates prepared using a monoclonal antibody reactive with PEN5 include two
polydisperse membrane-bound glycoproteins, PEN5c i (120-170 kD) and PEN50 (210-245 kD) .
Enzymatic deglycosylation reduces the apparent molecular weight of both PEN5 isoforms by
80-90%, and classifies PEN50 as a mucinlike glycoprotein . The surface expression of the PEN5
epitope is downmodulated by stimuli that induce NK cell proliferation, and it is absent from
leukemic NK cells of patients with granular lymphocyte proliferative disorder. Taken together,
these results indicate that PEN5 is a developmentally regulated poly-N-lactosamine epitope associated
with a mucin-type glycoprotein, whose expression is restricted to the population of nonproliferative
NK cells fully committed to cytolytic effector function .
N
K cells are large granular lymphocytes (LGLs)t com-
prising 2-15% ofPBMC in healthy individuals (1) . Al-
though NK cells do not rearrange or express either of the
known antigen receptor complexes, they can recognize and
kill a specific repertoire of virus-infected and transformed cells
in a non-MHC-restricted fashion (2) . With the exception
t Abbreviations used in this paper. ADCC, antibody-dependent cell cyto-
toxicity; APC, allophycocyanine; BC, bovine cornea keratan sulfate; BNC,
bovine nasal cartilage aggrecan ; CD1, embryonic chick cartilage aggrecan;
G1cNac, N-acetyl glucosamine ; GLPD, granular lymphocyte proliferative
disorder; LCM, leucocyte-conditioned medium ; LGL, large granular
lymphocyte; N-CAM, neural cell adhesion molecule; PNgase, peptide-N
glycosidase.
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of CD16, an Fc receptor for Ig that recognizes Ab-coated
target cells (3), the NK cell surface receptors responsible for
target cell recognition have not been identified . The lack of
a defining surface receptor requires NK cells to be identified
by a combination ofphenotypic and functional characteristics.
Although most peripheral blood NK cells are CD3TCR - ,
CD16+, CD56+ (neural cell adhesion molecule [N-CAM])
LGL, there is substantial phenotypic and functional hetero-
geneity within this population (1) . For example, the surface
density of CD56 has been shown to define functionally dis-
tinct NK cell populations . CD56bright NK cells are largely
CD16- , agranular lymphocytes deficient in cytolytic effector
function, which proliferate vigorously in response to IL-2
and resemble embryonic/fetal NK cells (4-6) . By contrast,
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lytic effector function, which proliferate very poorly in re-
sponse to IL-2 (4, 5) . Because CD16 and CD56 are not re-
stricted to thelymphocyte population (1), and aT cell subset
also expresses both CD16 and CD56 (1), these molecules
cannot define, by themselves, the NK cell population .
To identify cell surface structures more selectively expressed
on NK cells, we generated a panel of mousemAb reactive
with freshly isolated humanNK cells . In this article, we re-
port the molecular characterization ofPEN5, a sulfated poly-
N-lactosamine epitope whose expression is restricted, within
hematopoietic cells, to the functionally differentiated popu-
lation of LGL previously characterized as CD3TCR - ,
CD56di-, CD16+ cytolytic effectors. Because PEN5 is not
expressed on activated cytotoxic T cells, it can be used to
directly identify this important NK cell subset . We show
that PEN5 + NK cells are potent cytolytic effectors that
proliferate poorly in response to IL-2, whereas PEN5 - NK
cells are less potent cytolytic effectors that proliferate strongly
in response to IL-2 . The developmental regulation ofPEN5
expression suggests that its presence may be required forsome
aspect of NK cell function .
Materials and Methods
Reagents.
￿
Peptide-N-glycosidase (PNgase F) and Endo-cr-N-
acetylgalactosaminidase (O-glycanase) were used in the buffer
provided by the manufacturer (Oxford Glycosystems) . Keratanase
I (keratan sulfate 1,4 /3-n-galactanohydrolase ; ICN Biomedicals,
Cleveland, OH), keratanase II which attacks oversulfated forms of
keratan sulfate resistant to keratanase I (Seikagaku America, Inc .,
Rockville, MD) and neuraminidase (Calbiochem-Novabiochem
Corp., La Jolla, CA) were used in either PBS, PNgase F or O-gly-
canase buffers . Chondroitinase ABC (ICN Biomedicals) was used
in sodium acetate 0.05 M, pH 7.4 . Bovine cornea keratan sulfate
(BC), as well as other glycoaminoglycans and carbohydrates, were
purchased from Sigma . Trypsin, chymotrypsin, pronaseEand strep-
tavidin were also obtained from Sigma Chemical Co. (St . Louis,
MO). Allophycocyanine (APC) was obtained from Molecular
Probes, Inc . (Eugene, OR).
Antibodies . Mouse mAb reactive with CD2 (SFC13Pt2H9,
IgGl), CD3 (SFCIRW2-8C8, IgGI), CD56 (N901, IgGl), and
CD20 (H299, IgG2a), as well as isotype-matched control mouse
mAb (IgG and IgM) were obtained from Coulter Electronics (Hi-
aleah, FL) . The anti-PEN5 mAb (5H10, IgM) was produced by
immunizing BALB/c mice with digitonin-permeabilized periph-
eral bloodNK cells (7). Radioiodination ofPEN5 mAb was per-
formed using Iodobeads (Pierce, Rockford, IL) as previously de-
scribed (8) . The characterization of the anti-CD16 mAb (3G8,
IgGl), and the anti-keratan sulfatemAb 5134 (IgM) was reported
elsewhere (9, 10) . Thefollowing mAb recognize distinct epitopes
on most keratin sulfate chains : 1134 (IgG), 2133 (IgG), 3132 (IgM),
4131 (IgM), and 8C2 (IgM) (11) . FITC-labeled goat anti-mouse
Ig (G+M) was purchased from Tago Inc . (Burlingame, CA).
Cells.
￿
All cells were cultured in final medium consisting of
RPMI 1640 (Whittaker Bioproducts, Walkersville, MD) sup-
plementedwith 10% FCS, 1mM sodium pyruvate, 2 rnM gluta-
mine, and 50 ug/ml gentamycin, all obtained fromGIBCO BRL
(Gaithersburg,MD). Peripheral blood sampleswere obtained from
healthy volunteers . Purified NK and T cells were isolated from
PBMC by negative selection using immunomagnetic bead deple-
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tion (12) . In some experiments, NK cells and cell subsets
(CD56h°gh` and CD56d'm) were further purified by cell sorting on
an Epics Vflow cytometer (Coulter Electronics) after staining with
anti-CD56 mAb . Activation ofNK cellswas as described previously
(13) . PBMC from three patients with a CD3TCR- , CD16+,
CD56+ granular lymphocyte proliferative disorder (GLPD) (14),
were isolated by Ficoll-Hypaque gradient centrifugation . TheNK
cell line NKL was derived from one of these patients (Robertson,
M. J., unpublished results) . Splenic B cells were isolated and acti-
vated as described (15) . The isolation of peripheral B cells, mono-
cytes, and thymocytes was performed using standard methods
(16-18) . Peripheral blood platelets were kindly obtained from Dr.
E. Weinman (Beth Israel Hospital,NewYork). RBC were obtained
from peripheral blood, and granulocytes were purified by Ficoll-
Hypaque gradient centrifugation andRBC lysis. T4C1 and T4T8C1
CTL clones, as well as YTN17, 3.3 NK cell lines, have been de-
scribed elsewhere (19-22) . Other allogenic CTLclones were gener-
ated by limiting dilutions in rIL2-containing final medium, after
8 d ofMLR between PBL (5 x 106/ml) and the EBVtransformed
lymphoblastoid cell line JY (106/ml) .
Immunoprecipitations .
￿
Cells were resuspended in PBS and sub-
jected to radioiodination using "'I by the lactoperoxidase method
(23) . Sepharose-boundimmune complexes were washed four times
in lysis buffer, and eluted either directly into sample buffer (2%
SDS, 10% glycerol, 0.1MTris-HCI,pH 6.8,0.02% bromophenol
blue) before electrophoretic separation, or in elution buffer (0.15M
NH4OH, pH 10.5) before deglycosylation experiments .
Deglycosylation o,fRadioiodinatedPEN5 Glycoproteins.
￿
Radioio-
dinated PEN5 samples eluted from 5H10-coated Sepharose beads
were dried under vacuum and resuspended in appropriate
deglycosylated enzyme buffers . Thefollowing enzymes were used
alone or in combination : PNgase F (310 U/ml), O-glycanase (0.06
U/ml), keratanase I (0.25 U/ml), and neuraminidase (0.2 U/ml).
Deglycosylation was for 24 h at 37°C.
ELISAforAggrecan-type Proteoglyans.
￿
Wells ofmicrotiter plates
were incubated with 10 ug/ml solutions ofthe indicated aggrecan-
type proteoglycans overnight at 4°C. After washing, wells were
incubated with 0.1MTris, pH 7.6, containing 1% BSA, or with
the indicated enzymes in this buffer. After enzymatic digestion,
a standard ELISA was performed using 1:1,000 dilution of 5H10
(anti-PEN5) and 5134 (anti-keratan sulfate) mAb, and 1:500 dilu-
tion of anti-mouse Ig(G+M) conjugated with alkaline phospha-
tase. Colorwasdeveloped usingp-nitrophenyl phosphate substrate
in 0.86M diethanolamine, pH 9.8 . All absorbance values are the
mean of4 wells (SD <10%)and have been corrected for nonspecific
binding of the second Ab .
NK Cell Cytotoxicity and Proliferation Assays.
￿
NK cells were pre-
pared from PBMC by negative selection using immunomagnetic
beads (12) . These cells were double labeled with rhodamine-
conjugated 5H10 (anti-PEN5) andFITC-conjugated anti-CD3 and
sorted on an Epics V flow cytometer (Coulter Electronics) to iso-
late CD3-PEN5+ and CD3 -PEN5 - subsets . Post-sort analysis
confirmed that the selected markers were >98% present or absent
from the indicated population . These cells were then assayed for
target cell killing and IL2-mediated proliferation using standard
methods (5) . The reported stimulation indexwas calculated as : [av-
eragecpm(IL-2 cultures)/averagecpm (media cultures)] . An iden-
tical analysis was performed using NK cells labeled first with anti-
CD56 (NKH1, IgGl) followed by FITC-labeled goat anti-mouse
IgG, and second with rhodamine-conjugated 5H10 (anti-PEN5) .
These cells were sorted for CD56+PEN5+ and CD56+PEN5 -
populations, and assayed for cytotoxicity and proliferation as de-
scribed above .Results
Expression ofPENS on Hematopoetic Cells.
￿
To identify novel
cell surface structures selectively expressed on NK cells, we
generated a panel of mouse mAb (anti-PEN mAb) that rec-
ognizedNK cells but not T cells. The hematopoietic expres-
sion of one of these mAb (5H10, anti-PEN5) was found to
be restricted toNK cells. As shown in Fig . 1, two-color flow
cytometric analysis of PBL revealed PEN5 to be expressed
on the majority of CD56+ (Fig. 1, upper left) and CD16+
(Fig . 1, upper right) PBL . In contrast, PEN5 was not expressed
on CD3+ T cells (Fig. 1, lower left) or on CD20+ B cells
(Fig . 1, lower right) . NeitherT cell activation induced by mito-
genic concentrations ofPHA nor Con A, nor B cell activa-
tion induced byStaphylococcus aureusCowan strain I, for 1-6 d,
induced the cell surface expression of thePEN5 epitope (Table
1) . Similarly, a panel of allogeneic cytotoxic T cell clones
(CD3+CD4+CD56 - , CD3+CD8+CD56 - as well as
CD3+CD4+CD56+) did not express the PEN5 epitope
(Table 2) . Cell surface staining of monocytes, granulocytes,
platelets, and erythrocytes also failed to reveal the PEN5 epi-
tope (Table 1), confirming thatPEN5 is anNK cell-restricted
molecule. To more precisely analyze the expression ofPEN5
on NK cells, flow cytometric analysis of PEN5 expression
was performed on freshly isolated peripheral blood NK cells
purified by negative selection using immunomagnetic bead
depletion (see Materials and Methods) . PEN5 was brightly
expressed on 71.7 ± 3.5% (mean ± SEM, n = 16) ofthese
NK cell preparations whose average phenotype was 75.6 ±
Figure 1 .
￿
PEN5 expression on PBL . PBL were stained by two-color
flow cytometry using the indicated mAbs. Numbers in each quadrant in-
dicate the percentage of positively stained cells.
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Table 1 .
￿
Cell Surface Expression ofPENS on Hematopoietic Cells
Cell type
￿
Relative expression
Peripheral blood T cells
Activated T cells$
Thymocytes
Peripheral blood NK cells
￿
+ +
NK cell lines : YT.N17
￿
-
3.3
￿
±
NKL
￿
-
Peripheal blood B cells
Splenic B cells
Activated B cellss
Monocytes
Granulocytes
Platelets
RBC
" The cell surface expression of 5H10 was assessed by indirect immu-
nofluorescence and flow cytometry; (-) <5% positive stained cells ; (±)
between 5 and 35% positive-stained cells ; (+ +) >60% positive stained
cells .
t Peripheral blood T cells were activated with optimal mitogenic con-
centrations ofPHA and Con A, and immunofluorescence staining was
performed at days 2, 4, and 6 after activation .
S Splenic B cells were activated with optimal mitogenic concentrations
of Staphylococcus aureus Cowan strain 1, and immunofluorescence stain-
ing was performed at days 2, 4, and 6 after activation .
3 .3% CD56+, 74.2 ± 4.0% CD16+, and 8.3 ± 3.5%
CD3+ .
The phenotypic heterogeneity of peripheral blood NK cells
required amore careful comparison of the relative expression
of PEN5 and CD56 . The two-color flow cytometric com-
parison shown in Fig . 1, suggested that PEN5 was preferen-
tially expressed on the CD56d"" population . This was
confirmed by comparing the expression ofPEN5 on sorted
populations of CD56d'm and CD56brighl NK cells (Fig . 2) .
PEN5 was expressed at a high density on 85.9 ± 2.2% of
CD56dim NK cells (n = 4), and at low density on 31.1 ±
5 .3% of CD56bright NK cells . These results indicate that
high density cell surface expression of the PEN5 epitope is
restricted to the functionally differentiated CD56d'm NK
cells . These results also indicate that the cell surface expres-
sion of PEN5 defines two distinct subsets of NK cells,
PEN5+ and PEN5d'ml - which overlap with the CD56d'm
and CD56bright NK cell subsets, respectively. Because the rel-
ative expression ofCD56 on the surface ofNK cells has been
shown to correlate with their proliferative capacity and cyto-
lytic effector function (4), we compared the ability of highly
purified populations of PEN5+ and PEN5 - NK cells to
proliferate in response to IL-2 and effect natural cytotoxicity.
Mononuclear cells enriched for NK cells by magnetic beaddepletion (see Materials and Methods) were sorted into
PEN5+ and PEN5 - cell populations that were either CD3 -
(Fig. 3, top) or CD56+ (Fig. 3, bottom) . In both cases,
PEN5+ NK cells killed K562 and Molt-4 targets more effec-
tively than PEN5 - NK cells. Conversely, the IL-2 induced
proliferation of PEN5 - cells (stimulation index = 14 ± 6
[n = 3] in CD3 - sorted cells and 14 ± 8 in CD56+ sorted
cells) was significantly greater than that of PEN5+ cells
UnsortedNK cells
CD56 dimNK cells
CD56 brightNK cells
s
Control CD56
Fluorescence Intensity
PEN5
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s
s
PENS
The cell surface phenotype of the indicated T cell clones was performed by immunofluorescence and flow cytometry . (-) <5% positive stained
cells ; (+) >60% positive-stained cells .
(Stimulation index = 2.3 ± 1.7 [n = 3] in CD3 - cells and
3.1 ± 1.7 in CD56+ cells) . These results establish the
phenotypic and functional similarities between PEN5+ cells
and CD56di- cells, and PEN5' cells and CD56b°eht cells,
respectively.
PENS Expression Is Downregulated by NK Cell Activa-
tion . CD56dim and CD56b°eht NK cells strongly differ in
their response to proliferative stimuli (4, 5, 24) : CD56dim
23 .
Figure 2 .
￿
Expression of PEN5 on distinct NK cell subsets . Unsorted NK cells, or sorted CD56
￿
and CD56b6sht NK cells were analyzed for the
expression of 5H10 using biotinylated anti-PEN5 mAb and APC-conjugated streptavidin . Controls were performed using mouse isotype-matched con-
trol mAb . The numbers in each histogram indicate the percentage of positively stained cells .
Table 2 . Absence of Surface Expression ofPENS on Cytotoxic T Cell Clones
Cell surface expression
Clone CD3 CD2 CD4 C138 CD56
T4Cl " + +
6.5 B4 + +
6.5 C1 + +
20.1 A2 + +
8.17 A + +
20.1 D8 + +
T4T8C1 + +L d a
E 0
U
Days ofculture
0
6
8
10
14
20
K562
￿
MOLT-4
E/T RATIO
Fluorescence Intensity
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CD56 dimNK cells
￿
CD56
bright NK cells
Control CD56 PEN5 Control CD56 PEN5
1
￿
10 100
￿
1
￿
10 100
￿
1
￿
10 100
￿
1
￿
16 100
￿
1
￿
16 100
￿
'1
￿
10 160
Figure 3.
￿
Natural cytotoxicity mediatedby
purified populations of PEN5+ and PEN5 -
NK cells . (Top) NK cells were sorted for
CD3-PEN5- (O) and CD3-PEN5' (" )
populations. (Bottom)NK cells were sorted for
CD56+PEN5- (O) and CD56+PEN5* (" )
populations . Results are representative of three
independent experiments using different
donors.
Figure 4 .
￿
Kinetics of PEN5 expression on
activated NK cells . Sorted CD56dim and
CD56brigh, NK cells were activated for 20 d
with ionomycin andLCM as described (13).
At theindicated times, aliquots ofthe activated
NK cell populations were analyzed for their
cell surface phenotype by flow cytometry using
isotype-matched control mAb, anti-CD56 and
5H10mAb. Results indicate thepercentage of
positively stained cells (%) ; the total mean
fluorescence intensity is indicated below.
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~NK cells proliferate very poorly in response to IL-2, whereas
CD56bright NK cells proliferate in response to this stimulus .
However, CD56dim NK cells can be induced to proliferate
in response to a combination ofLCM and ionomycin (24) .
We took advantage ofthis observation to correlate PEN5 ex-
pression with the proliferative state of sorted CD56dim and
CD56bright NK cells . The cell surface expression of CD56
and PENS was determined on both NK cell subsets by flow
cytometic analysis at the indicated time intervals after activa-
tion (Fig. 4) . Activation of CD56d'm NK cells resulted in the
temporal reduction ofPENS expression. In parallel, the cell
surface expression of CD56 was temporally increased, and
after 20 d of activation, the cell surface expression ofPENS
and CD56 on the CD56dim NK cells was largely similar to
that of unactivated CD56b°ght NK cells (i.e., PEN5di-I - and
CD56bright). These results are consistent with the absence of
PENS from the cell surface of long-term humanNK cell clones
(Moretta, A ., personal communication) . In addition, PENS
was not expressed on leukemic NK cells (CD3TCR - ,
CD16+, CD56+) isolated from patients with GLPD (Fig .
5) . Finally, PENS was absent or dimly expressed on three
long-term human NK cell lines, YT.N17, 3.3, NKL (Table
1) . These results indicate that PEN5 expression inversely corre-
lates with the proliferative capacity of NK cells .
Biochemical Characterization ofthe PEN5 Epitope.
￿
Radio-
iodinated lysates prepared from restingNK cells wereimmu-
noprecipitated using the 5H10 (anti-PEN5)mAb or an isotype-
matched control mAb . Immunoprecipitates were then sepa-
rated under nonreducing conditions on SDS-polyacrylamide
gels. As shown in Fig. 6, two diffuse bands were selectively
immunoprecipitated by the 5H10mAb . The average molec-
E
d u
Control CD56 PEN5
F-] 3
Fluorescence Intensity
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Figure 5 .
￿
Cell surface expression of PENS epitope on leukemic NK
cells. Peripheral blood NK cells, as well as PBMC isolated from three pa-
tients undergoing GLPD blast crisis (GLPD1-3) were analyzed for the
cell surface expression of CD56 and PEN5 using indirect immunofluores-
cence and flow cytometry. The numbers in each histogram indicate the
percentage of positively stained cells .
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Figure 6 . Immunoprecipita-
tion of PENS glycoproteins . De-
tergent lysates prepared from
radioiodinatedNK cells were im-
munoprecipitated using 5H10
mAb or mouse IgM control .
Samples were then separated under
nonreducing conditions on a6%
SDS-polyacrylamide gel .
ular weight of the larger species, PEN5a, was 227 ± 4 kD
(n = 12 different donors) . The molecular weight range of
the polydispersedPEN5a species was 210 ± 3-245 ± 5 kD .
The average molecular weight of the smaller species, PEN50
was 140 ± 3 kD, with a range of 123 ± 3 to 170 ± 4W .
The migration ofbothPEN5a andamolecules as polydisperse
bands suggested that they were highly glycosylated. This was
confirmed in the deglycosylation experiments shown in Fig .
7 . PEN5a and /3 were affinity purified from radioiodinated
NK cell lysates using anti-PEN5mAb and eluted as described
in Materials and Methods. The eluted glycoproteins were
treated with the indicated enzymes before electrophoretic sepa-
ration on an SDS-polyacrylamide gel. Compared with the
migration of untreated PENS glycoproteins (Fig. 7, lane 1),
PNgase F treatment induced the disappearance ofPEN5a
from the 210-245-kD range, and the appearance of a deglyco-
sylated form ofPEN5a migrating at 20-25 kD (Fig. 7, lane
6, c2) . In contrast, the apparent mobility ofPEN50 was re-
duced by only -20 kD after PNgase F incubation . Treat-
ment ofPEN5 glycoproteins with O-glycanase (Fig . 7, lane
3) did not significantly affect their SDS-PAGE migration pat-
tern. These results indicate that thePEN5a andPEN50 differ
markedly in their carbohydrate attachment sites, and that
80-90% of the apparent molecular weight ofPEN5a is due
to N-linked carbohydrates . Although the recognition ofPENS
in Western blots was weak, the epitope was expressed on
both PEN5a and PEN50 (data not shown) .
The extensive Winked glycosylation ofPEN5a suggested
that it might be amember of one ofthe classes ofglycoproteins
characterized by such high carbohydrate content (50-90%),
such as proteoglycans. Affinity purified radioiodinatedPEN5a
and (3 molecules were digested by enzymes that cleave theFigure 7.
￿
Enzymatic deglycosylation ofPENS glycoproteins . Affinity-
purified PEN5a and 0 glycoproteins were eluted from antibody-coated
Sepharose beads, then subjected to deglycosylation for 24 h at 37°C using
PNgase F (lane6), O-glycanase (lane 3), keratanase I (lane 2), O-glycanase
and keratanase (lane 4), neuraminidase (lane 5), and PNgase F and neur-
aminidase (lane 7) and appropriate buffers. Control eluates incubated in
PBS without any enzymes were separated in lane 1 . Samples were sepa-
rated under nonreducing conditions on a 6-12% SDS-polyacrylamide gra-
dient gel .
glycosaminoglycan side chains from proteoglycan core pro-
teins. Chondroitinase ABC, heparitinase and heparinase did
not affect the migration pattern ofPEN5a or PEN5a (data
not shown) . By contrast, incubation ofPENS molecules with
keratanase I reduced the apparent molecular weight ofPEN5a
from 210-245 to 35-40 kD (Fig. 7, lane 2, c1) . It is likely
that the difference between the PNgase F-digested (35-40
kD) c1 core protein (Fig. 7, lane 2) and the keratanase-digested
(25-30 kD) c2 core protein (Fig. 7, lane 4), results from a
more complete deglycosylation of the PEN5a glycoprotein .
Whereas keratanase treatment only slightly reduced the poly-
dispersity of PEN5a, the combination of O-glycanase and
keratanase I treatment reduced the apparent molecular weight
ofPEN5a from 120-170 to 25-30kD (Fig. 7, lane 4) . Taken
together, these results indicate that PEN5a contains 80-90%
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N-linked keratanase I-sensitive carbohydrates, whereasPEN5a
contains 80-90% O-linked carbohydrates and keratanase I-sen-
sitive chains. This extensive O-linked glycosylation is consis-
tent with PEN5a being a mucinlike glycoprotein . In addi-
tion, treatment with neuraminidase induced a slight reduction
in the polydispersity, as well as a shift in the apparent molec-
ular weight ofboth PEN5a and a, indicating that sialic acid
residues are also present on both glycoproteins (Fig . 7, lane
5) . Treatment of PENS glycoproteins with a combination
ofPNGase F and neuraminidase (Fig . 7, lane 7), resulted in
the same effect thatPNGase F had alone, confirming the pres-
ence ofterminal sialic acid residues on Winked carbohydrates
present on PEN5a . The cl and c2 deglycosylated forms of
PEN5a and a proteins were not immunoprecipitable by the
51110mAb (data not shown), indicating that the epitope rec-
ognized by the anti-PENS mAb contains keratanase I-sensi-
tive carbohydrate chains .
Reactivity ofAnti-PENS mAb with Keratan Sufate Glycos-
aminoglycans . To test whether the anti-PENS mAb was
directly raised against keratan sulfate carbohydrates, we ex-
amined the effect ofexogenous keratan sulfate carbohydrates
on the binding of PENS mAb to NK cells. Radioiodinated
51110 (anti-PENS) mAb was combined with various con-
centrations of BC, and the mixture was then incubated with
NK cells. As shown in Fig. 8 A, the binding of radiolabeled
51110 mAb to NK cells was inhibited by BC keratan sulfate
in a dose-dependent manner. Preincubation ofNK cells with
the same concentrations of BC keratan sulfate followed by
washes, did not affect the binding of 51110 mAb (data not
shown), indicating that the anti-PENS mAb reacted with
carbohydrate determinants present on keratan sulfate glycos-
aminoglycans . Incubation of anti-PENS mAb with simple
sugars or other glycosaminoglycans was without any effect
(see legend to Fig. 8) . Furthermore, treatment of NK cells
with keratanase I induced a 58.5% ± 8.4 (n = 4) decrease
in the reactivity of 51110 mAb with NK cells (Fig . 8 B) .
Parallel treatment ofNK cells with chondroitinase ABC or
neuraminidase did not have any effect on 51110 reactivity.
Interestingly, the 51110 epitope was totally insensitive to
trypsin and chymotrypsin but was removed by pronase E treat-
ment . Finally, an ELISA was used to compare the binding
of 51110 (anti-PENS) and 5D4 (anti-keratan sulfate) to the
keratan sulfate/chondroitin sulfate proteoglycans expressed in
cartilage from different species . As shown in Fig. 8 C (top),
the 51110 mAb (solid ban) recognized aggrecan-type pro-
teoglycans derived from embryonic chick cartilage (CD1, top)
and from bovine nasal cartilage (BNC, middle) . As a positive
control, the anti-keratan sulfatemAb5D4 (Fig . 8, open ban)
also reacted with untreatedCDl and BNC, whereas its reac-
tivity with keratanase-treated samples was reduced. Treatment
ofCD1 andBNC with either keratanase I or II, reduced 51110
reactivity. Treatment ofCDl and BNC with chondroitinase
ABC is known to increase the expression of keratan sulfate
epitopes (11) . Consequently, digestion ofCDl and BNC with
chondroitinaseABC increased the binding of both 51110 and
5D4 . As a negative control, neither mAb recognized the
Swarm rat chondrosarcoma aggrecan (RC), which does not
contain keratan sulfate (Fig. 8 C, bottom) . Although 5D4 alsoFigure 8 .
￿
Reactivity of anti-PEN5 mAb with keratan sulfate glycosaminoglycans. (A) 1 125-labeled 5H10 mAb (106 cpmAample) was preincubated
for 20 min at 4°C in PBS in the presence of the indicated concentrations ofBC. The mixture was then added toNK cells for another 20-min incubation
at 4°C, before three washes in PBS-1% BSA. Samples were counted in a .y-counter, and results are expressed as mean cpm of duplicate samples (SD
<10%). When used in incubation with NK cells or anti-PEN5 mAb, the following carbohydrates used at 10 mg/ml were without any effect on 5H10
binding toNK cell surface: chondroitin sulfate B, heparin, heparan sulfate, dextran sulfate, GlcNAc, mannose 6-phosphate, lactose, galactose-6-phosphate,
fucose, glucose 6-phosphate, glucose, and galactose. (B) Peripheral blood NK cells were incubated in PBS-1% BSA for 3 h or 45 min at 37°C with
glycosidases (0.025 U/ml) or proteases (5 fag/ml), respectively. Cell surface expression of PEN5 epitope was then analyzed by flow cytometry using
5H10 mAb. Percent modulation was calculated as the ratio of the total linear mean fluorescence intensity of the treated cells over that of untreated
control cells. (C) The antigenicity of 5H10 mAb for aggrecan proteoglycans was analyzed by ELISA as described in Materials and Methods . The anti-
keratan sulfatemAb 5D4 was used as a positive control. ChondroitinaseABC was used at 0.04 U/ml, keratanase I was used at 0.05 U/ml, and keratanase
II was used at 0.004 U/ml, for 1 h at 37°C .
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shark cranial cartilage (SHK), 5H10 did not . These results
indicate that the PENS epitope is present in some, but not
all, keratan sulfate chains, and is therefore distinct from the
standard sulfated poly-N-lactosamine repeat sequence,
Gala1-4(sulfated) G1cNAc . This result is consistent with the
inability of six distinct anti-keratan sulfatemAbs (1B4, 2D3,
3D2, 4D1, 8C2, and 5D4, data not shown) to bind toNK
cells. Preliminary results (Vivier, E ., and P. Anderson, manu-
script in preparation) using immunoelectron microscopyshow
that thePENS epitope is located some distance from the plasma
membrane (43.4 + 12.8 nm [n = 50]), suggesting that, like
other cell surface mucins, the membrane-bound glycopro-
teins carrying the PENS epitope are extended threadlike
proteins.
Discussion
We describe the identification and molecular characteriza-
tion ofPENS, a novel cell surface epitope selectively expressed
on peripheral blood NK cells. Several lines of evidence indi-
cate that the PENS epitope is an unusual sulfated poly-N-
lactosamine carbohydrate that can be expressed on keratan
sulfate glycosaminoglycans . First, keratan sulfate glycosamino-
glycans selectively compete withPENS molecules for binding
to the 5H10 (anti-PENS) mAb . Second, treatment of NK
cells with keratanase I reduces the cell surface expression of
the PENS epitope. This enzyme attacks sites where there is
an unsulfated Gal unit, which may be adjacent to a 6-sulfated
G1cNAc unit ; completely unsulfated disaccharides cannot serve
as substrates for this enzyme (25) . Third, the 5H10 mAb
recognizes epitopes located on keratan sulfate chains from
aggrecan-type proteoglycans obtained from embryonic chick
and bovine nasal cartilages. These keratan sulfate
glycosaminoglycans contain, as their prominent structure, a
repeating Galal-4G1cNac, disaccharides that can be sulfated
on either, or both saccharide units . Failure of the anti-PENS
mAb to recognize an epitope on a third aggrecan-type pro-
teoglycan, from shark cranial cartilage, suggests that this mAb
does not recognize a structure common to all keratan sulfate
chains . Further modification of keratan sulfate chains can re-
sult from differential fucoslyation, sialylation, or perhaps ad-
dition of other carbohydrates, such as mannose to the basic
repeating structure (26) . It is possible that the PENS epitope
might contain one, or more, unusual structures, which could
account for its presence in some, but not all, keratan sulfate
chains.
Immunoprecipitation ofNK cell detergent lysates with the
anti-PENSmAb, revealed two distinct glycoproteins, PEN5a
and PEN5a . Enzymatic deglycosylation indicated.that both
species were 80-90% carbohydrate by weight . This result
raises the possibility that these proteins are either proteoglycans
or mucinlike glycoproteins . Proteoglycans are high molec-
ular weight glycoproteins in which specific glycosaminoglycans
are bound to proteins via Gal-xylose-Ser linkages, with the
exception of keratan sulfate as discussed below (27) . PENS
molecules are free of xylose-linked carbohydrates, since the
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cell surface expression of PENS, and the SDS-PAGE migra-
tion ofbothPEN5a anda molecules are not affected by treat-
ments with chondroitinase ABC (Fig. 8 B), heparitinase,
heparinase, or p-nitrophenyl a-n-xylopyranoside (data not
shown) . However, the reactivity of anti-PENS mAbs with
sulfated poly-N-lactosamine carbohydrates present on keratan
sulfate glycosaminoglycans raises the possibility that PEN5a
and/or PEN5a glycoproteins may be cell surface-associated
keratan sulfate proteoglycans. Keratan sulfatemaybe Winked
or O-linked to core proteoglycan proteins (26) . To date,
O-linked keratan sulfate chains have been identified only in
cartilage, bone, and brain (26) . In the cornea, keratan sulfate
chains are Winked to Asn residues on 37- and 25-kD core
proteins (26) . The linkage oligosaccharide is related to bian-
tiennary oligosaccharides found in complex-type glycopro-
teins, with the keratan sulfate chain extending from one branch
and sialic acid terminating the second branch (28) . Antigeni-
cally similar core proteins, with similar molecular weight,
have been identified in a variety oftissues (29) . However, there
appears to be considerable variability in the glycosylation of
these keratan sulfatelike molecules. The PEN5a glycopro-
tein shares many of the same characteristics as these keratan
sulfatelike molecules . By contrast, PEN5a is an O-linked gly-
coprotein containing keratanase I-sensitive carbohydrates . It
has been reported that mucin-type glycoproteins secreted by
cultured hamster tracheal epithelial cells contain keratanase
I sensitive poly-N-lactosamine carbohydrates (30) . Mucinlike
glycoproteins are highly glycosylated proteins containing a
majority ofO-linked oligosaccharides, and are associated with
the cellmembrane in a number ofcell types (31) . Classification
ofPEN5a as aNK cell-specific membrane-bound mucinlike
glycoprotein is most consistent with our data . Therefore, if
PEN5a and PEN5a are associated, thePEN5a-Pen5a com-
plex may be analogous to theASGP-1-ASGP-2 complex de-
rived from ascitic mammary adenocarcinoma cells (32), in
which only one component (ASGP-1) of the complex is a
mucin-like glycoprotem. The precise biochemical identification
of the carbohydrates present on PEN5a and PEN5a glyco-
proteins, as well as the amino acid sequence of the core pro-
teins, will allow definitive classification .
Our results clearly show that the cell surface expression
of this unique sulfated poly-N-lactosamine carbohydrate is
restricted, within the hematopoetic compartment, toNK cells.
It is intriguing that other cell surface carbohydrates, such as
the acidic polylactosamine carbohydrate determinants CD57
(HNK-1) and sialyl-Lewisx-i in humans, and asialo-GM1
ganglioside in mice, have previously been identified on the
surface ofNK cells (1) . Taken together, these results suggest
that a general characteristic of NK cells is their expression
of several membrane-bound poly-N-lactosamine carbohydrates .
The selective expression of the PENS epitope on resting
CD56d'°t NK cells, and its downregulation in response to
NK cell proliferation, strongly suggest that PENS is a marker
offunctionally differentiated NK cells that are specialized for
cytolytic effector functions. It is possible that the absence of
PENS expression on CD56bagbt, NK cells and GLPD cells
reflects a developmentally regulated shift in the activities ofglycosyltransferases involved in keratan sulfate metabolism .
Modulation of glycosyltransferase activities induced by cell
differentiation and activation has been described in several
cell types including T lymphocytes (33, 34) .
Some of the biochemical features of PENS glycoproteins
point theway forthestudyof their function . First, carbohy-
drates aremajormediators ofcell-cell interactions (35) . Second,
in their protease-resistance as well as their extended rodlike
structure, in addition to thehigh extent ofPEN50 O-glyco-
sylation, the PENS glycoproteins resemble epithelial cell
mucins . Since the mucin-type glycoproteins serve a protec-
tive role on the epithelial cell surface, it is tempting to specu-
late that PENS glycoproteins protectNK cellsfrom their own
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